← back to search

Carla S. Coffin

University of Calgary · CA
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, and Hepatitis Viruses Studies and Epidemiology.
h-index
40
citations
5,469
works
235
NIH funding
primary concept
email

Recent publications

Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Journal of Hepatology 2025cited by 16position: middledoi
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
˜The œLancet. Gastroenterology & hepatology 2023cited by 94position: middledoi
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Journal of Hepatology 2023cited by 91position: middledoi
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Journal of Hepatology 2023cited by 61position: middledoi
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
PLoS ONE 2021cited by 14position: middledoi
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
World Journal of Gastroenterology 2020cited by 246position: middledoi
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
Human Vaccines & Immunotherapeutics 2019cited by 86position: middledoi
New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection
Gastroenterology 2018cited by 143position: firstdoi
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Journal of Hepatology 2015cited by 184position: middledoi
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
Journal of Hepatology 2015cited by 104position: middledoi
Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy
Canadian Journal of Gastroenterology 2013cited by 168position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Edward Gane · New Zealand Christians in Science2 papers (2015–2021)Anuj Gaggar · Gilead Sciences (United States)2 papers (2015–2021)Young‐Suk Lim · Ulsan College1 papers (2015–2015)G. Mani Subramanian · Pacific Biosciences (United States)1 papers (2015–2015) · 1 papers (2019–2019)Megan Wind‐Rotolo · Agios Pharmaceuticals (United States)1 papers (2015–2015)Dong Xu · King University1 papers (2015–2015)Yoon Jun Kim · Pusan National University1 papers (2015–2015)David Cohen · AstraZeneca (Netherlands)1 papers (2015–2015)Tania Santodomino-Garzon · University of Calgary1 papers (2013–2013) · 1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2015–2015) · 1 papers (2019–2019)Robert P. Myers · Meta (United States)1 papers (2013–2013) · 1 papers (2021–2021)Wai‐Kay Seto · Chinese University of Hong Kong1 papers (2021–2021) · 1 papers (2019–2019)Shyamasundaran Kottilil · University of Maryland, Baltimore1 papers (2015–2015)Alexander Thompson · The University of Melbourne1 papers (2021–2021)